Aileron Therapeutics, Inc. (ALRN)
NASDAQ: ALRN · IEX Real-Time Price · USD
2.740
-0.060 (-2.14%)
At close: Jul 19, 2024, 4:30 PM
2.730
-0.010 (-0.36%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Aileron Therapeutics Market Cap
Aileron Therapeutics has a market cap or net worth of $59.22 million as of July 22, 2024. Its market cap has increased by 565.44% in one year.
Market Cap
59.22M
Enterprise Value
47.16M
1-Year Change
565.44%
Ranking
Category
Stock Price
$2.74
Market Cap Chart
Since June 29, 2017, Aileron Therapeutics's market cap has decreased from $158.90M to $59.22M, a decrease of -62.73%. That is a compound annual growth rate of -13.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 59.20M | 328.99% |
| Dec 29, 2023 | 13.80M | 27.78% |
| Dec 30, 2022 | 10.80M | -78.82% |
| Dec 31, 2021 | 51.00M | 20.57% |
| Dec 31, 2020 | 42.30M | 166.04% |
| Dec 31, 2019 | 15.90M | 28.23% |
| Dec 31, 2018 | 12.40M | -92.01% |
| Dec 29, 2017 | 155.10M | -2.39% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SELLAS Life Sciences Group | 64.11M |
| Vor Biopharma | 63.02M |
| HOOKIPA Pharma | 61.99M |
| Allakos | 61.02M |
| ProPhase Labs | 59.52M |
| InspireMD | 58.91M |
| VolitionRx | 58.88M |
| Enzo Biochem | 58.66M |